Salt substitute use was at or below 5.4% among US adults from 2003 to 2020, with use up to 10.5% in those with treated hypertension.

The Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines Spikevax ® and mNexspike ®. The updated mRNA vaccines target the LP.8.1 variant of ...

Adjuvant treatment with NSAIDs can improve disease-free survival and delay recurrence in patients with resected CRC, data suggest.

California, Oregon, and Washington will join in a new West Coast Health Alliance which will guide state vaccine policy.

Patients with cancer may have medical debt in collections that persists for years after their diagnosis, despite high rates of insurance coverage.

The HHS withdrew their report the Alcohol Intake and Health Study which concluded that even 1 drink a day posed health risks.

Egrifta WR, a new concentrated formulation (F8) of tesamorelin, is now available for HIV-related lipodystrophy.

Tegoprazan has comparable efficacy to proton pump inhibitors for H pylori eradication, with added benefit in clarithromycin-resistant strains.

The FDA created a green list of approved active pharmaceutical ingredients in the GLP-1 drugs to keep unverified ingredients out of the US.

Two doses of RZV were effective against HZ among adult patients aged 50 years and older with autoimmune diseases.

Mean glycated hemoglobin levels are lower in children with type 1 diabetes who have access to modern monitoring technology and insulin.

Oral semaglutide was linked to reduced SU levels among patients with T2D, particularly among individuals with hyperuricemia and those who switched from a DPP-4 inhibitor.